Displaying 1–24 of 24 results for Heidi Parsons, Managing Editor
Experts give some Big Pharma companies high marks for their environmental initiatives. Benchmarking efforts and new tools promise to make it easier for all drug companies, regardless of size, to improve performance and reduce costs.
In a year when 'change' is the watchword in politics, even a key pharmaceutical industry trade show seems to have caught change fever. Philadelphia will surely benefit; what can attendees look forward to?
Managing Editor, Heidi Parsons, wants YOU to help build the Pharma Manufacturing community.
The move away from the blockbuster model toward ever more narrowly targeted therapeutics is slowly but surely in progress, promising to transform not just drugmaking, but the entire healthcare system.
Bonnie Haferkamp was a successful engineer in Life Sciences at Rockwell Automation, putting to good use her degree in chemical engineering. Then her mother was stricken with a rare neurological disorder, and Haferkamp said goodbye to industry to pursue a PhD and devote herself to research in ...
Speaking at the recent Personalized Medicine Conference at Harvard Medical School, Eli Lilly and Co. President and COO John Lechleiter discussed how pharmaceutical manufacturers are preparing for the sea change thats coming as the entire healthcare industry moves toward the use of targeted ...
Standards will help establish for diagnostics what USP monographs do for drug safety: An interview with Critical Path President/CEO Dr. Raymond Woosley.
Managing Editor Heidi Parsons talks with Bosch Rexroth and Parsec Automation about the need to improve Overall Equipment Effectiveness (OEE) while enhancing operator safety.
When executives at Koreas Samchully Pharmaceuticals sought out the machinery they would need to expand their oligonucleotides business, they got more than steel and tubing. They forged a trans-global relationship with a U.S. equipment supplier that is introducing them to PAT.
Here's a look at what's hot in machine vision systems and a basic preview of next month's Pack Expo show. In addition, this online report includes information on x-ray inspection systems and other packaging equipment you're likely to see on the show floor.
Australian biotech firm Biota's experience with licensing an antiviral candidate to Glaxo provides a cautionary tale for both small biotech R&D companies and the larger pharma firms to which they license compounds.
Debate over the regulatory fate of biosimilars seesaws between strong differences of opinion; can the parties achieve a balance?
Couldnt make the trip to Chicago? The weather outside was frightful, but the technology was cutting edge. Pharmaceutical Manufacturings editors take a look at who and what was at this years conference.
Manhattan in the spring, a bustling show floor and thought-provoking educational sessions provide all the reason anyone should need to attend this years event
Business pressures are bringing pharmaceutical companies to a realization that some other industries have had for years: profesionals with operations management skills are vital to the success of the enterprise.
A packaging expert offers pointers on what pharmaceutical manufacturers need to know and to specify in order to ensure favorable outcomes.
A June 26 report issued by Rep. Henry Waxman took FDA to task for what it cited as a dramatic decline in enforcement activity during the past five years. The Agency's reply was official yet defensive.